Humacyte, Inc.
Clinical trials sponsored by Humacyte, Inc., explained in plain language.
A biotech company developing bioengineered human tissues and organs.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
Lab-Grown blood vessels could save limbs after trauma
Disease control CompletedThis trial is testing whether a lab-grown blood vessel made from human collagen can safely replace damaged arteries in people with life- or limb-threatening vascular injuries below the neck. Participants receive the artificial vessel as a bypass or replacement during emergency su…
Phase: PHASE2, PHASE3 • Sponsor: Humacyte, Inc. • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Engineered blood vessel could simplify dialysis for kidney patients
Disease control CompletedThis phase 3 trial tested a lab-grown blood vessel (Human Acellular Vessel, or HAV) against the standard surgically created fistula in 242 people with end-stage kidney disease on hemodialysis. The goal was to see which option works better for providing reliable access to filter b…
Phase: PHASE3 • Sponsor: Humacyte, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC